Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period (BMI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01592058|
Recruitment Status : Completed
First Posted : May 4, 2012
Last Update Posted : July 31, 2012
The purpose of this study is to learn whether women who use progestin-only methods of birth control such as the contraceptive implant (Implanon), the levonorgestral-releasing IUS (Mirena), or depot medroxyprogesterone acetate(DMPA) will experience weight change compared to women using the non-hormonal copper IUC (ParaGard).
The investigators primary hypothesis is that users of DMPA will gain excess weight and increase their BMI above the copper-IUC users; secondarily, the investigators will compare users' data in the LNG-IUC and ENG implant groups to the copper-IUC group.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||427 participants|
|Official Title:||Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period|
|Study Start Date :||June 2010|
|Actual Primary Completion Date :||May 2012|
|Actual Study Completion Date :||May 2012|
- Weight [ Time Frame: Baseline and 12 months ]Change in weight from baseline at 12 months.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01592058
|United States, Missouri|
|Washington University School of Medicine|
|Saint Louis, Missouri, United States, 63110|
|Principal Investigator:||Tessa E Madden, MD, MPH||Washington University School of Medicine|